-
公开(公告)号:US20140186474A1
公开(公告)日:2014-07-03
申请号:US14125427
申请日:2011-06-13
IPC分类号: A61K36/752 , A61L12/14
CPC分类号: A61L12/14 , A01N65/36 , A61K31/353 , A61K36/752 , C11D3/0078 , C11D7/267
摘要: The present invention relates to compositions and methods for eye and contact lens care. More particularly, the invention relates to ophthalmic compositions which contain at least one bioflavonoid component for ocular care, preserving ophthalmic solutions and/or disinfecting contact lenses.
摘要翻译: 本发明涉及用于眼睛和隐形眼镜护理的组合物和方法。 更具体地说,本发明涉及含有至少一种用于眼部护理的生物类黄酮成分,保存眼用溶液和/或消毒隐形眼镜的眼用组合物。
-
公开(公告)号:US20140255332A1
公开(公告)日:2014-09-11
申请号:US14239288
申请日:2012-08-24
申请人: Francesca Crawford , Philip Gunning
发明人: Francesca Crawford , Philip Gunning
IPC分类号: A61K31/79
CPC分类号: A61K31/79 , A61K9/0048 , A61K33/18 , A61K47/38 , A61K2300/00
摘要: There is provided inter alia a germicidal aqueous formulation, suitable for use in the eye, which has a pH of from 4.0 to 6.5 and which comprises 4.0 to 7.5% w/w of povidone-iodine and a viscosity increasing agent, the formulation buffered with a buffer concentration of 25 mM to 75 mM.
摘要翻译: 特别提供适用于眼睛的杀菌含水制剂,其具有4.0至6.5的pH,并且其包含4.0至7.5重量%的聚维酮碘和增粘剂,所述制剂用 缓冲液浓度为25mM至75mM。
-
公开(公告)号:US20070154906A1
公开(公告)日:2007-07-05
申请号:US11544191
申请日:2006-10-05
CPC分类号: A61K31/711 , G16B35/00 , G16C20/60
摘要: The invention provides systematic methods for identification of candidate compounds useful in treatment of conditions initiated or modulated by genetic expression. The methods of the invention permit efficient identification of candidates suitable for verification testing by in vitro and/or in vivo models.
摘要翻译: 本发明提供了用于鉴定可用于治疗由遗传表达启动或调节的病症的候选化合物的系统方法。 本发明的方法允许通过体外和/或体内模型有效鉴定适合于验证测试的候选物。
-
公开(公告)号:US09931428B2
公开(公告)日:2018-04-03
申请号:US14125427
申请日:2011-06-13
IPC分类号: A61K36/752 , A61L12/14 , A61K31/353 , A01N65/36 , C11D3/00 , C11D7/26
CPC分类号: A61L12/14 , A01N65/36 , A61K31/353 , A61K36/752 , C11D3/0078 , C11D7/267
摘要: The present invention relates to compositions and methods for eye and contact lens care. More particularly, the invention relates to ophthalmic compositions which contain at least one bioflavonoid component for ocular care, preserving ophthalmic solutions and/or disinfecting contact lenses.
-
-
-